Transcriptomic profile of cHL by EBV/HIV status. (A) Principal component analysis (PCA), where each point is a sample, and color represents EBV/HIV status to highlight variation in RNA expression by EBV/HIV status. (B) Differentially enriched pathways from the Hallmark gene set database as determined by gene set variation analysis. Only significantly altered pathways (Padj < .1) are included. P values were adjusting using Benjamini-Hochberg. (C) Volcano plot of differentially expressed genes by EBV in HIV– tumors. Points indicate genes enriched in EBV–/HIV– (left) and EBV+/HIV– (right) tumors. (D) Volcano plot of differentially expressed genes by HIV in EBV+ tumors. Points indicate genes enriched in EBV+/HIV– (left) and EBV+/HIV+ (right) tumors. Cut-offs for inclusion: |Log2FC| > 1, Padj < .05. lncRNA and Y chromosome genes were excluded from volcano plots. PC1, principal component 1; PC2, principal component 2.
Figure 2.

Transcriptomic profile of cHL by EBV/HIV status. (A) Principal component analysis (PCA), where each point is a sample, and color represents EBV/HIV status to highlight variation in RNA expression by EBV/HIV status. (B) Differentially enriched pathways from the Hallmark gene set database as determined by gene set variation analysis. Only significantly altered pathways (Padj < .1) are included. P values were adjusting using Benjamini-Hochberg. (C) Volcano plot of differentially expressed genes by EBV in HIV tumors. Points indicate genes enriched in EBV/HIV (left) and EBV+/HIV (right) tumors. (D) Volcano plot of differentially expressed genes by HIV in EBV+ tumors. Points indicate genes enriched in EBV+/HIV (left) and EBV+/HIV+ (right) tumors. Cut-offs for inclusion: |Log2FC| > 1, Padj < .05. lncRNA and Y chromosome genes were excluded from volcano plots. PC1, principal component 1; PC2, principal component 2.

or Create an Account

Close Modal
Close Modal